| Detailed information |
|---|
| CancerLivER ID | 2092 |
| Biomarker | DLC1 |
| Biomarker Name/Symbol (given in Publication) | DLC1 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | DLC-1 could be a direct indicator or marker for the invasion and prognosis of HCC; but not validated on independent dataset |
| Experimental Condition | Cancer v/s Normal; predict survival of patients |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 26846339 |
| Type of Biomarker | Prognostic |
| Pathway | Rho A/ROCK2 pathway |
| Cohort | Paired tumor and adjacent non-tumor tissue sample obtained from 80 patients consisted of 19 females and 61 males with ages ranging between 36 and 78 years old (mean age: 65 years old). |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2016 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |